$EXEL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EXELIXIS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in EXELIXIS, INC.. Get notifications about new insider transactions in EXELIXIS, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Option Exercise | A | 22.48 | 16,598 | 373,123 | 16,598 | |
| May 28 2021 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Grant | A | 0.00 | 8,299 | 0 | 74,414 | 66.1 K to 74.4 K (+12.55 %) |
| May 28 2021 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | A | 22.48 | 33,549 | 754,182 | 33,549 | |
| May 28 2021 | EXEL | EXELIXIS, INC. | POSTE GEORGE | Director | Grant | A | 0.00 | 16,424 | 0 | 173,614 | 157.2 K to 173.6 K (+10.45 %) |
| May 18 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Sell | S | 24.73 | 14,593 | 360,885 | 280,994 | 295.6 K to 281 K (-4.94 %) |
| May 18 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Payment of Exercise | F | 25.56 | 3,026 | 77,345 | 295,587 | 298.6 K to 295.6 K (-1.01 %) |
| May 17 2021 | EXEL | EXELIXIS, INC. | POSTE GEORGE | Director | Sell | S | 24.97 | 40,802 | 1,018,826 | 157,190 | 198 K to 157.2 K (-20.61 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Option Exercise | M | 4.20 | 50,000 | 210,000 | 100,000 | |
| May 14 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 19,722 | 0 | 1,038,789 | 1 M to 1 M (+1.94 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 19,722 | 0 | 491,813 | 511.5 K to 491.8 K (-3.86 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Payment of Exercise | F | 25.16 | 30,278 | 761,794 | 511,535 | 541.8 K to 511.5 K (-5.59 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Buy | M | 4.20 | 50,000 | 210,000 | 541,813 | 491.8 K to 541.8 K (+10.17 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 40,616 | 0 | 1,019,067 | 1.1 M to 1 M (-3.83 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Option Exercise | M | 1.90 | 100,000 | 190,000 | 150,000 | |
| May 14 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Sell | S | 25.38 | 100,000 | 2,538,000 | 614,078 | 714.1 K to 614.1 K (-14.00 %) |
| May 14 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Buy | M | 1.90 | 100,000 | 190,000 | 714,078 | 614.1 K to 714.1 K (+16.28 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 3.38 | 40,000 | 135,200 | 0 | |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 3.13 | 40,000 | 125,200 | 0 | |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 6.30 | 40,000 | 252,000 | 0 | |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 25.01 | 5,473 | 136,880 | 1,288,127 | 1.3 M to 1.3 M (-0.42 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 3.38 | 40,000 | 135,200 | 1,293,600 | 1.3 M to 1.3 M (+3.19 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 25.00 | 5,075 | 126,875 | 1,253,600 | 1.3 M to 1.3 M (-0.40 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 3.13 | 40,000 | 125,200 | 1,258,675 | 1.2 M to 1.3 M (+3.28 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Sell | S | 24.95 | 10,222 | 255,039 | 1,218,675 | 1.2 M to 1.2 M (-0.83 %) |
| May 13 2021 | EXEL | EXELIXIS, INC. | PAPADOPOULOS STELIOS | Director | Buy | M | 6.30 | 40,000 | 252,000 | 1,228,897 | 1.2 M to 1.2 M (+3.36 %) |
| Apr 28 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Option Exercise | M | 1.70 | 50,000 | 85,000 | 0 | |
| Apr 28 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Sell | S | 25.00 | 50,000 | 1,250,000 | 613,482 | 663.5 K to 613.5 K (-7.54 %) |
| Apr 28 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Buy | M | 1.70 | 50,000 | 85,000 | 663,482 | 613.5 K to 663.5 K (+8.15 %) |
| Apr 28 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Sell | S | 25.03 | 7,665 | 191,855 | 297,392 | 305.1 K to 297.4 K (-2.51 %) |
| Apr 28 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Sell | S | 25.03 | 18,000 | 450,540 | 628,248 | 646.2 K to 628.2 K (-2.79 %) |
| Apr 02 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 1.70 | 60,000 | 102,000 | 0 | |
| Apr 02 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 22.96 | 60,000 | 1,377,600 | 389,467 | 449.5 K to 389.5 K (-13.35 %) |
| Apr 02 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 1.70 | 60,000 | 102,000 | 449,467 | 389.5 K to 449.5 K (+15.41 %) |
| Apr 02 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Option Exercise | M | 1.70 | 50,000 | 85,000 | 50,000 | |
| Apr 02 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Sell | S | 23.00 | 50,000 | 1,150,000 | 613,482 | 663.5 K to 613.5 K (-7.54 %) |
| Apr 02 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Buy | M | 1.70 | 50,000 | 85,000 | 663,482 | 613.5 K to 663.5 K (+8.15 %) |
| Mar 31 2021 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Option Exercise | M | 3.38 | 40,000 | 135,200 | 0 | |
| Mar 31 2021 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Sell | S | 22.64 | 6,220 | 140,821 | 231,589 | 237.8 K to 231.6 K (-2.62 %) |
| Mar 31 2021 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Buy | M | 3.38 | 40,000 | 135,200 | 237,809 | 197.8 K to 237.8 K (+20.22 %) |
| Mar 31 2021 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Option Exercise | M | 3.38 | 40,000 | 135,200 | 0 | |
| Mar 31 2021 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Sell | S | 22.64 | 6,220 | 140,821 | 231,589 | 237.8 K to 231.6 K (-2.62 %) |
| Mar 31 2021 | EXEL | EXELIXIS, INC. | WYSZOMIERSKI JACK L | Director | Buy | M | 3.38 | 40,000 | 135,200 | 237,809 | 197.8 K to 237.8 K (+20.22 %) |
| Mar 17 2021 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Option Exercise | M | 3.38 | 40,000 | 135,200 | 0 | |
| Mar 17 2021 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Sell | S | 23.60 | 40,000 | 944,000 | 12,718 | 52.7 K to 12.7 K (-75.88 %) |
| Mar 17 2021 | EXEL | EXELIXIS, INC. | Garber Alan M | Director | Buy | M | 3.38 | 40,000 | 135,200 | 52,718 | 12.7 K to 52.7 K (+314.51 %) |
| Mar 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Option Exercise | A | 21.31 | 494,700 | 10,542,057 | 494,700 | |
| Mar 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 67,374 | 0 | 1,059,683 | 992.3 K to 1.1 M (+6.79 %) |
| Mar 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 67,374 | 0 | 491,813 | 559.2 K to 491.8 K (-12.05 %) |
| Mar 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Grant | A | 0.00 | 72,885 | 0 | 613,482 | 540.6 K to 613.5 K (+13.48 %) |
| Mar 05 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Grant | A | 0.00 | 57,135 | 0 | 646,248 | 589.1 K to 646.2 K (+9.70 %) |
| Mar 05 2021 | EXEL | EXELIXIS, INC. | Senner Christopher J. | EVP and CFO | Grant | A | 0.00 | 64,150 | 0 | 356,591 | 292.4 K to 356.6 K (+21.94 %) |
| Mar 05 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Grant | A | 0.00 | 59,570 | 0 | 305,057 | 245.5 K to 305.1 K (+24.27 %) |
| Mar 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 49,395 | 0 | 389,467 | 340.1 K to 389.5 K (+14.52 %) |
| Mar 03 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 1.70 | 65,000 | 110,500 | 60,000 | |
| Mar 03 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 22.11 | 65,000 | 1,437,150 | 340,072 | 405.1 K to 340.1 K (-16.05 %) |
| Mar 03 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 1.70 | 65,000 | 110,500 | 405,072 | 340.1 K to 405.1 K (+19.11 %) |
| Feb 26 2021 | EXEL | EXELIXIS, INC. | COHEN CHARLES | Director | Option Exercise | M | 3.38 | 40,000 | 135,200 | 0 | |
| Feb 26 2021 | EXEL | EXELIXIS, INC. | COHEN CHARLES | Director | Sell | S | 22.69 | 40,000 | 907,600 | 181,375 | 221.4 K to 181.4 K (-18.07 %) |
| Feb 26 2021 | EXEL | EXELIXIS, INC. | COHEN CHARLES | Director | Buy | M | 3.38 | 40,000 | 135,200 | 221,375 | 181.4 K to 221.4 K (+22.05 %) |
| Feb 24 2021 | EXEL | EXELIXIS, INC. | POSTE GEORGE | Director | Option Exercise | M | 3.38 | 40,000 | 135,200 | 0 | |
| Feb 24 2021 | EXEL | EXELIXIS, INC. | POSTE GEORGE | Director | Buy | M | 3.38 | 40,000 | 135,200 | 197,992 | 158 K to 198 K (+25.32 %) |
| Feb 24 2021 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Sell | S | 22.29 | 24,097 | 537,122 | 66,115 | 90.2 K to 66.1 K (-26.71 %) |
| Feb 24 2021 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Option Exercise | M | 3.38 | 40,000 | 135,200 | 0 | |
| Feb 24 2021 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Sell | S | 22.34 | 800 | 17,872 | 424,415 | 425.2 K to 424.4 K (-0.19 %) |
| Feb 24 2021 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Sell | S | 21.92 | 39,200 | 859,264 | 425,215 | 464.4 K to 425.2 K (-8.44 %) |
| Feb 24 2021 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Buy | M | 3.38 | 40,000 | 135,200 | 464,415 | 424.4 K to 464.4 K (+9.42 %) |
| Feb 24 2021 | EXEL | EXELIXIS, INC. | WILLSEY LANCE | Director | Sell | S | 21.90 | 50,000 | 1,095,000 | 424,415 | 474.4 K to 424.4 K (-10.54 %) |
| Feb 19 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Option Exercise | M | 1.70 | 50,000 | 85,000 | 100,000 | |
| Feb 19 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Option Exercise | M | 1.70 | 50,000 | 85,000 | 150,000 | |
| Feb 19 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Sell | S | 22.35 | 50,000 | 1,117,500 | 540,597 | 590.6 K to 540.6 K (-8.47 %) |
| Feb 19 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Buy | M | 1.70 | 50,000 | 85,000 | 590,597 | 540.6 K to 590.6 K (+9.25 %) |
| Feb 19 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Sell | S | 22.50 | 50,000 | 1,125,000 | 540,597 | 590.6 K to 540.6 K (-8.47 %) |
| Feb 19 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Buy | M | 1.70 | 50,000 | 85,000 | 590,597 | 540.6 K to 590.6 K (+9.25 %) |
| Feb 17 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Payment of Exercise | F | 21.91 | 1,400 | 30,674 | 245,487 | 246.9 K to 245.5 K (-0.57 %) |
| Feb 17 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Sell | S | 21.57 | 45,000 | 970,650 | 246,887 | 291.9 K to 246.9 K (-15.42 %) |
| Feb 17 2021 | EXEL | EXELIXIS, INC. | Senner Christopher J. | EVP and CFO | Payment of Exercise | F | 21.91 | 4,105 | 89,941 | 292,441 | 296.5 K to 292.4 K (-1.38 %) |
| Feb 17 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Payment of Exercise | F | 21.91 | 1,685 | 36,918 | 589,113 | 590.8 K to 589.1 K (-0.29 %) |
| Feb 17 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Payment of Exercise | F | 21.91 | 2,858 | 62,619 | 540,597 | 543.5 K to 540.6 K (-0.53 %) |
| Feb 17 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Payment of Exercise | F | 21.91 | 9,789 | 214,477 | 559,187 | 569 K to 559.2 K (-1.72 %) |
| Feb 17 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 21.91 | 3,718 | 81,461 | 340,072 | 343.8 K to 340.1 K (-1.08 %) |
| Feb 17 2021 | EXEL | EXELIXIS, INC. | FELDBAUM CARL B | Director | Option Exercise | M | 3.38 | 20,000 | 67,600 | 0 | |
| Feb 17 2021 | EXEL | EXELIXIS, INC. | FELDBAUM CARL B | Director | Sell | S | 21.96 | 20,000 | 439,200 | 8,521 | 28.5 K to 8.5 K (-70.12 %) |
| Feb 17 2021 | EXEL | EXELIXIS, INC. | FELDBAUM CARL B | Director | Buy | M | 3.38 | 20,000 | 67,600 | 28,521 | 8.5 K to 28.5 K (+234.71 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Payment of Exercise | F | 22.56 | 65,190 | 1,470,686 | 568,976 | 634.2 K to 569 K (-10.28 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Grant | A | 0.00 | 224,287 | 0 | 634,166 | 409.9 K to 634.2 K (+54.72 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Grant | A | 0.00 | 23,238 | 0 | 409,879 | 386.6 K to 409.9 K (+6.01 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 126,565 | 0 | 992,309 | 1.1 M to 992.3 K (-11.31 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 187,239 | 0 | 1,118,874 | 931.6 K to 1.1 M (+20.10 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 187,239 | 0 | 386,641 | 573.9 K to 386.6 K (-32.63 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 22.56 | 19,997 | 451,132 | 343,790 | 363.8 K to 343.8 K (-5.50 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 71,293 | 0 | 363,787 | 292.5 K to 363.8 K (+24.37 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 9,370 | 0 | 292,494 | 283.1 K to 292.5 K (+3.31 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Payment of Exercise | F | 22.56 | 15,365 | 346,634 | 590,798 | 606.2 K to 590.8 K (-2.53 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Grant | A | 0.00 | 59,411 | 0 | 606,163 | 546.8 K to 606.2 K (+10.87 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Grant | A | 0.00 | 4,998 | 0 | 546,752 | 541.8 K to 546.8 K (+0.92 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Payment of Exercise | F | 22.56 | 14,982 | 337,994 | 543,455 | 558.4 K to 543.5 K (-2.68 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Grant | A | 0.00 | 71,293 | 0 | 558,437 | 487.1 K to 558.4 K (+14.63 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Grant | A | 0.00 | 9,745 | 0 | 487,144 | 477.4 K to 487.1 K (+2.04 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Payment of Exercise | F | 22.56 | 11,267 | 254,184 | 291,887 | 303.2 K to 291.9 K (-3.72 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Grant | A | 0.00 | 59,411 | 0 | 303,154 | 243.7 K to 303.2 K (+24.37 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Grant | A | 0.00 | 4,498 | 0 | 243,743 | 239.2 K to 243.7 K (+1.88 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Senner Christopher J. | EVP and CFO | Payment of Exercise | F | 22.56 | 18,206 | 410,727 | 296,546 | 314.8 K to 296.5 K (-5.78 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Senner Christopher J. | EVP and CFO | Grant | A | 0.00 | 59,411 | 0 | 314,752 | 255.3 K to 314.8 K (+23.27 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Senner Christopher J. | EVP and CFO | Grant | A | 0.00 | 9,745 | 0 | 255,341 | 245.6 K to 255.3 K (+3.97 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Payment of Exercise | F | 22.56 | 65,190 | 1,470,686 | 568,976 | 634.2 K to 569 K (-10.28 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Grant | A | 0.00 | 224,287 | 0 | 634,166 | 409.9 K to 634.2 K (+54.72 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Grant | A | 0.00 | 23,238 | 0 | 409,879 | 386.6 K to 409.9 K (+6.01 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 126,565 | 0 | 992,309 | 1.1 M to 992.3 K (-11.31 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 187,239 | 0 | 1,118,874 | 931.6 K to 1.1 M (+20.10 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Gift | G | 0.00 | 187,239 | 0 | 386,641 | 573.9 K to 386.6 K (-32.63 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 22.56 | 19,997 | 451,132 | 343,790 | 363.8 K to 343.8 K (-5.50 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 71,293 | 0 | 363,787 | 292.5 K to 363.8 K (+24.37 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 9,370 | 0 | 292,494 | 283.1 K to 292.5 K (+3.31 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Payment of Exercise | F | 22.56 | 15,365 | 346,634 | 590,798 | 606.2 K to 590.8 K (-2.53 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Grant | A | 0.00 | 59,411 | 0 | 606,163 | 546.8 K to 606.2 K (+10.87 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Grant | A | 0.00 | 4,998 | 0 | 546,752 | 541.8 K to 546.8 K (+0.92 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Payment of Exercise | F | 22.56 | 14,982 | 337,994 | 543,455 | 558.4 K to 543.5 K (-2.68 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Grant | A | 0.00 | 71,293 | 0 | 558,437 | 487.1 K to 558.4 K (+14.63 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres, Prod Dev & Me ... | Grant | A | 0.00 | 9,745 | 0 | 487,144 | 477.4 K to 487.1 K (+2.04 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Payment of Exercise | F | 22.56 | 11,267 | 254,184 | 291,887 | 303.2 K to 291.9 K (-3.72 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Grant | A | 0.00 | 59,411 | 0 | 303,154 | 243.7 K to 303.2 K (+24.37 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Haley Patrick J. | EVP, Commercial | Grant | A | 0.00 | 4,498 | 0 | 243,743 | 239.2 K to 243.7 K (+1.88 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Senner Christopher J. | EVP and CFO | Payment of Exercise | F | 22.56 | 18,206 | 410,727 | 296,546 | 314.8 K to 296.5 K (-5.78 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Senner Christopher J. | EVP and CFO | Grant | A | 0.00 | 59,411 | 0 | 314,752 | 255.3 K to 314.8 K (+23.27 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Senner Christopher J. | EVP and CFO | Grant | A | 0.00 | 9,745 | 0 | 255,341 | 245.6 K to 255.3 K (+3.97 %) |
| Feb 03 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 1.70 | 65,000 | 110,500 | 125,000 | |
| Feb 03 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 22.08 | 65,000 | 1,435,200 | 283,124 | 348.1 K to 283.1 K (-18.67 %) |
| Feb 03 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 1.70 | 65,000 | 110,500 | 348,124 | 283.1 K to 348.1 K (+22.96 %) |
| Jan 14 2021 | EXEL | EXELIXIS, INC. | Senner Christopher J. | EVP and CFO | Option Exercise | M | 3.66 | 30,000 | 109,800 | 90,000 | |
| Jan 14 2021 | EXEL | EXELIXIS, INC. | Senner Christopher J. | EVP and CFO | Sell | S | 25.00 | 30,000 | 750,000 | 245,596 | 275.6 K to 245.6 K (-10.89 %) |
| Jan 14 2021 | EXEL | EXELIXIS, INC. | Senner Christopher J. | EVP and CFO | Buy | M | 3.66 | 30,000 | 109,800 | 275,596 | 245.6 K to 275.6 K (+12.22 %) |
| Jan 06 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 1.70 | 65,000 | 110,500 | 190,000 | |
| Jan 06 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 20.32 | 65,000 | 1,320,800 | 283,124 | 348.1 K to 283.1 K (-18.67 %) |
| Jan 06 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 1.70 | 65,000 | 110,500 | 348,124 | 283.1 K to 348.1 K (+22.96 %) |
| Jan 06 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Option Exercise | M | 1.90 | 20,000 | 38,000 | 0 | |
| Jan 06 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Option Exercise | M | 7.27 | 30,000 | 218,100 | 0 | |
| Jan 06 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Buy | M | 1.90 | 20,000 | 38,000 | 541,754 | 521.8 K to 541.8 K (+3.83 %) |
| Jan 06 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Buy | M | 7.27 | 30,000 | 218,100 | 521,754 | 491.8 K to 521.8 K (+6.10 %) |
| Jan 06 2021 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Gift | G | 0.00 | 2,500 | 0 | 491,754 | 494.3 K to 491.8 K (-0.51 %) |
| Dec 22 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 1.70 | 65,000 | 110,500 | 255,000 | |
| Dec 22 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 20.01 | 65,000 | 1,300,650 | 283,124 | 348.1 K to 283.1 K (-18.67 %) |
| Dec 22 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 1.70 | 65,000 | 110,500 | 348,124 | 283.1 K to 348.1 K (+22.96 %) |
| Nov 25 2020 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Option Exercise | M | 5.82 | 40,004 | 232,823 | 0 | |
| Nov 25 2020 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Sell | S | 18.50 | 40,004 | 740,074 | 90,212 | 130.2 K to 90.2 K (-30.72 %) |
| Nov 25 2020 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Buy | M | 5.82 | 40,004 | 232,823 | 130,216 | 90.2 K to 130.2 K (+44.34 %) |
| Nov 25 2020 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Option Exercise | M | 5.82 | 40,004 | 232,823 | 0 | |
| Nov 25 2020 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Sell | S | 18.50 | 40,004 | 740,074 | 90,212 | 130.2 K to 90.2 K (-30.72 %) |
| Nov 25 2020 | EXEL | EXELIXIS, INC. | MARCHESI VINCENT T | Director | Buy | M | 5.82 | 40,004 | 232,823 | 130,216 | 90.2 K to 130.2 K (+44.34 %) |
| Nov 17 2020 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Payment of Exercise | F | 20.16 | 7,898 | 159,224 | 573,880 | 581.8 K to 573.9 K (-1.36 %) |
| Nov 17 2020 | EXEL | EXELIXIS, INC. | MORRISSEY MICHAEL | President and CEO | Payment of Exercise | F | 20.16 | 10,530 | 212,285 | 581,778 | 592.3 K to 581.8 K (-1.78 %) |